BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22470123)

  • 1. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.
    Hoffman GE; Le WW; Entezam A; Otsuka N; Tong ZB; Nelson L; Flaws JA; McDonald JH; Jafar S; Usdin K
    J Histochem Cytochem; 2012 Jun; 60(6):439-56. PubMed ID: 22470123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.
    Conca Dioguardi C; Uslu B; Haynes M; Kurus M; Gul M; Miao DQ; De Santis L; Ferrari M; Bellone S; Santin A; Giulivi C; Hoffman G; Usdin K; Johnson J
    Mol Hum Reprod; 2016 Jun; 22(6):384-96. PubMed ID: 26965313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An explanation of the mechanisms underlying fragile X-associated premature ovarian insufficiency.
    Rose BI; Brown SE
    J Assist Reprod Genet; 2020 Jun; 37(6):1313-1322. PubMed ID: 32377997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FMRpolyG accumulates in FMR1 premutation granulosa cells.
    Friedman-Gohas M; Elizur SE; Dratviman-Storobinsky O; Aizer A; Haas J; Raanani H; Orvieto R; Cohen Y
    J Ovarian Res; 2020 Feb; 13(1):22. PubMed ID: 32101156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.
    Lu C; Lin L; Tan H; Wu H; Sherman SL; Gao F; Jin P; Chen D
    Hum Mol Genet; 2012 Dec; 21(23):5039-47. PubMed ID: 22914733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of key signaling pathways involved in oocyte maturation in FMR1 premutation carriers with Fragile X-associated primary ovarian insufficiency.
    Alvarez-Mora MI; Rodriguez-Revenga L; Madrigal I; Garcia-Garcia F; Duran M; Dopazo J; Estivill X; Milà M
    Gene; 2015 Oct; 571(1):52-7. PubMed ID: 26095811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic expression of CGG-repeats alters ovarian response to gonadotropins and leads to infertility in a murine FMR1 premutation model.
    Shelly KE; Candelaria NR; Li Z; Allen EG; Jin P; Nelson DL
    Hum Mol Genet; 2021 May; 30(10):923-938. PubMed ID: 33856019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unstable mutations in the FMR1 gene and the phenotypes.
    Loesch D; Hagerman R
    Adv Exp Med Biol; 2012; 769():78-114. PubMed ID: 23560306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding decreased fertility in women carriers of the FMR1 premutation: a possible mechanism for Fragile X-Associated Primary Ovarian Insufficiency (FXPOI).
    Peprah E
    Reprod Health; 2014 Aug; 11():67. PubMed ID: 25134882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency.
    Rosario R; Stewart HL; Choudhury NR; Michlewski G; Charlet-Berguerand N; Anderson RA
    FASEB J; 2022 Nov; 36(11):e22612. PubMed ID: 36250920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve.
    Rehnitz J; Alcoba DD; Brum IS; Dietrich JE; Youness B; Hinderhofer K; Messmer B; Freis A; Strowitzki T; Germeyer A
    Reprod Biol Endocrinol; 2018 Jul; 16(1):65. PubMed ID: 29981579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers.
    Friedman-Gohas M; Orvieto R; Michaeli A; Aizer A; Kirshenbaum M; Cohen Y
    Sci Rep; 2021 Jul; 11(1):14139. PubMed ID: 34238973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tremor-Ataxia syndrome and primary ovarian insufficiency in an
    Saldarriaga-Gil W; Rodriguez-Guerrero T; Fandiño-Losada A; Ramirez-Cheyne J
    Colomb Med (Cali); 2017 Sep; 48(3):148-151. PubMed ID: 29299012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FMRP Associates with Cytoplasmic Granules at the Onset of Meiosis in the Human Oocyte.
    Rosario R; Filis P; Tessyman V; Kinnell H; Childs AJ; Gray NK; Anderson RA
    PLoS One; 2016; 11(10):e0163987. PubMed ID: 27695106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fragile X syndrome and FMR1-dependent diseases - clinical presentation, epidemiology and molecular background].
    Landowska A; Rzońca S; Bal J; Gos M
    Dev Period Med; 2018; 22(1):14-21. PubMed ID: 29641417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the role of FMR1 CGG trinucleotide repeats in Jordanian poor ovarian responders.
    Batiha O; Shaaban ST; Al-Smadi M; Jarun Y; Maswadeh A; Alahmad NA; Al-Talib MM
    Gene; 2021 Jan; 767():145174. PubMed ID: 33007370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGG repeat in the FMR1 gene: size matters.
    Willemsen R; Levenga J; Oostra BA
    Clin Genet; 2011 Sep; 80(3):214-25. PubMed ID: 21651511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Genome Instability in the Fragile X-Related Disorders.
    Hayward BE; Usdin K
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.